Loading…
Targeted Delivery of Persulfides to the Gut: Effects on the Microbiome
Persulfides (R−SSH) have been hypothesized as potent redox modulators and signaling compounds. Reported herein is the synthesis, characterization, and in vivo evaluation of a persulfide donor that releases N‐acetyl cysteine persulfide (NAC‐SSH) in response to the prokaryote‐specific enzyme nitroredu...
Saved in:
Published in: | Angewandte Chemie International Edition 2021-03, Vol.60 (11), p.6061-6067 |
---|---|
Main Authors: | , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Persulfides (R−SSH) have been hypothesized as potent redox modulators and signaling compounds. Reported herein is the synthesis, characterization, and in vivo evaluation of a persulfide donor that releases N‐acetyl cysteine persulfide (NAC‐SSH) in response to the prokaryote‐specific enzyme nitroreductase. The donor, termed NDP‐NAC, decomposed in response to E. coli nitroreductase, resulting in release of NAC‐SSH. NDP‐NAC elicited gastroprotective effects in mice that were not observed in animals treated with control compounds incapable of persulfide release or in animals treated with Na2S. NDP‐NAC induced these effects by the upregulation of beneficial small‐ and medium‐chain fatty acids and through increasing growth of Turicibacter sanguinis, a beneficial gut bacterium. It also decreased the populations of Synergistales bacteria, opportunistic pathogens implicated in gastrointestinal infections. This study reveals the possibility of maintaining gut health or treating microbiome‐related diseases by the targeted delivery of reactive sulfur species.
The persulfide donor NDP‐NAC (see structure) was synthesized and found to decompose in response to E. coli nitroreductase with the release of N‐acetyl cysteine persulfide (NAC‐SSH). NDP‐NAC elicited gastroprotective effects in mice by the upregulation of beneficial small‐ and medium‐chain fatty acids, by increasing growth of Turicibacter sanguinis, a beneficial gut bacterium, and by decreasing populations of pathogenic Synergistales bacteria. |
---|---|
ISSN: | 1433-7851 1521-3773 |
DOI: | 10.1002/anie.202014052 |